Articles from Shanghai Immunocan Biotech Co., Ltd.
Immunocan Achieves Megabase-Scale Human Immunoglobulin Gene Replacement in Rabbits, Creating a Cross-Species Data Engine for AI-Driven Antibody Discovery
Shanghai Immunocan Biotech Co., Ltd. (“Immunocan”) today announced the successful in situ replacement of megabase (Mb)-scale human immunoglobulin (Ig) gene segments at endogenous Ig loci in rabbits using its proprietary MASIRT® (Massive-fragment Across Species In situ Replacement Technology) platform.
By Shanghai Immunocan Biotech Co., Ltd. · Via Business Wire · November 4, 2026